Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.

BACKGROUND Despite its favorable long-term safety profile, side effects during dimethyl fumarate (DMF) treatment for psoriasis are not uncommon and may lead to treatment suspension. The association between side effects, especially gastrointestinal, and dietary habits has not yet been specifically addressed. METHODS This observational, cross-sectional study aimed to assess the dietary habits of patients with moderate-to-severe plaque psoriasis in treatment with DMF who attended three Italian psoriasis clinics. Demographic and clinical data, including any side effects, were collected from the patients' medical records. A self-administered questionnaire recorded and scored: 1) if meals are eaten regularly or not; 2) daily intake at meals of fatty foods, milk and dairy products, alcohol, fruit and vegetables; and 3) in the case of side effects, the time between eating and their onset. RESULTS We included 53 patients in treatment with DMF at a daily dose of 232.4±194.1 mg for 38±29.8 weeks. Thirty-eight (71.7%) reported side effects, namely flushing (60.5%), diarrhea (44.7%), gastralgia (29%) and nausea (15.8%). Overweight seemed associated with the occurrence of side effects. In 47.4% of subjects, side effects appeared within 2 hours of having a meal. Daily fat intake appeared to protect against side effects, albeit without statistical significance; skipping meals was correlated with their onset in subjects complaining of diarrhea. CONCLUSIONS Finding some correlation between dietary habits and occurrence of side effects during DMF treatment requires further investigation with the aim of developing possible strategies to improve its tolerability and retention rate.

[1]  K. Asadullah,et al.  Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas , 2022, Dermatology and Therapy.

[2]  L. Naldi,et al.  Efficacy and safety of Dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real‐world clinical experience , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  G. Valpiani,et al.  Dimethyl fumarate treatment for psoriasis in a real‐life setting: A multicentric retrospective study , 2021, Dermatologic therapy.

[4]  G. Fabbrocini,et al.  Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis , 2021, Drugs in context.

[5]  L. Naldi,et al.  Clinical use of dimethyl fumarate in moderate‐to‐severe plaque‐type psoriasis: a European expert consensus , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  H. Dickel,et al.  Long‐term real‐life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single‐centre, retrospective, observational study , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  J. Szepietowski,et al.  Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE) , 2017, The British journal of dermatology.

[8]  L. Donini,et al.  The New Modern Mediterranean Diet Italian Pyramid. , 2016, Annali di igiene : medicina preventiva e di comunita.

[9]  M. Kelson,et al.  Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments , 2016, The British journal of dermatology.

[10]  R. Fox,et al.  Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study , 2015, Neurology and Therapy.

[11]  E. de Luca d'Alessandro,et al.  Dietary habits in Italy: the importance of the Mediterranean diet. , 2012, Annali di igiene : medicina preventiva e di comunita.

[12]  L. Naldi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  Khusru Asadullah,et al.  Dimethylfumarate for psoriasis: more than a dietary curiosity. , 2005, Trends in molecular medicine.